Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
1143.7000 -10.20 (-0.88%)
NSE Jul 17, 2026 15:31 PM
Volume: 1.2M
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
1143.70
-0.88%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading above all available SMAs
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - July 17, 2026
The Baseline | 17 Jul 2026, 04:48PM
Market closes higher, led by a surge in banking and IT stocks
Trendlyne Marketwatch | 17 Jul 2026, 04:11PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020